WO2008023574A1 - Formule en émulsion de sensation d'utilisation agréable - Google Patents
Formule en émulsion de sensation d'utilisation agréable Download PDFInfo
- Publication number
- WO2008023574A1 WO2008023574A1 PCT/JP2007/065598 JP2007065598W WO2008023574A1 WO 2008023574 A1 WO2008023574 A1 WO 2008023574A1 JP 2007065598 W JP2007065598 W JP 2007065598W WO 2008023574 A1 WO2008023574 A1 WO 2008023574A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- oil
- hyaluronic acid
- extract
- acid
- acetylated
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/062—Oil-in-water emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/965—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of inanimate origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
- A61K8/9711—Phaeophycota or Phaeophyta [brown algae], e.g. Fucus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Definitions
- the present invention relates to an emulsified composition containing an alge colloid and hyaluronic acid and having a smooth feeling of use, particularly an emulsified composition suitable for an external preparation for skin.
- Alge colloid and hyaluronic acid are components that are known to have excellent moisturizing action and blood circulation promoting action, and are widely used in cosmetics and the like.
- Arge colloid is a natural component extracted from brown algae, and it is mainly composed of alginic acid, which is a polysaccharide composed of / 3-1,4 bonds of ⁇ D mannuronic acid and ⁇ L-guluronic acid.
- Argecoloid is known to have an excellent moisturizing effect and a skin beautifying effect.
- Hyaluronic acid is a high molecular compound with a molecular weight of several millions, which has a disaccharide repeating structure consisting of a / 3-glycoside bond of D-glucuronic acid and D-N-acetylylcosamine. Since hyaluronic acid has a very long acidic sugar chain, it has a high ability to hold water.
- Cosmetics containing both alge colloid and hyaluronic acid include, for example, (ii) plant extracts of Lythraceae and Lagerstroemia, and (B) brown algae extract (Arge colloid). ) And other whitening agents, antioxidants, anti-inflammatory agents, UV protection agents, hyaluronic acid and other moisturizing agents, cell activators, and one or more physiologically active ingredients selected from the group consisting of blood flow promoters And skin cosmetics (Patent Document 1).
- the emulsified composition containing an alge colloid and hyaluronic acid lacked the smoothness at the time of use, and had a bad feeling of use.
- Patent Document 1 JP 2005-139070 A
- acetylated hyaluronic acid is a derivative obtained by acetylating a hydroxyl group of hyaluronic acid, and specifically has the following structural formula.
- n is a natural number
- the introduced acetyl group increases the hydrophobicity, so the affinity to the stratum corneum is high, the spinnability is low, and the solubility in alcohol is excellent. is doing.
- An object of the present invention is to provide a technique for imparting a smooth feeling to use to an emulsified composition such as a cosmetic containing an alge colloid and hyaluronic acid.
- the emulsion composition according to (1) or (2) which is an external preparation for skin.
- smoothness represents the degree of friction felt by the finger or the skin of the application part when the emulsion composition is applied to the skin.
- smoothness is measured by the force S, which is evaluated by using rheological properties such as viscosity, in addition to sensory evaluation by panelists.
- the emulsified composition of the present invention contains an alge colloid, hyaluronic acid and acetylated hyaluronic acid.
- the alge colloid is a natural component extracted from brown algae and contains alginic acid as a main component.
- Alginic acid is a polysaccharide composed of / 3- 1, 4-bond of / 3-D-mannuronic acid and a-L-daluronic acid.
- Arge colloid can be extracted from brown algae and used.
- a commercially available product such as a commercially available product, for example, Arge colloid (manufactured by BOTTGER) can be mentioned.
- the content of the algae colloid but are not particularly limited, and against the emulsified total composition 0.00;! ⁇ 5 weight 0/0 Ca preferred ⁇ , more preferably ⁇ (or 0 . 005-2 is the weight 0/0, in particular 0.0; preferably to 1% by weight!.
- hyaluronic acid is a high molecular compound having a molecular weight of several millions, which has a disaccharide repeating structure composed of a / 3-glycoside bond of D-glucuronic acid and D-N-acetylyldarcosamine. And its salts.
- the molecular weight of hyaluronic acid used in the present invention is not particularly limited, but is preferably 10,000 to 5,000,000, particularly preferably 100,000 to 2,000,000.
- Hyaluronic acid salts include sodium salts, potassium salts, lithium salts, magnesium salts, calcium salts and other metal salts, lysine salts, arginine salts, histidine salts and other basic amino acid salts, ammonium salts, and triethanolamine salts. And organic salts such as diisopropanolamine salt.
- sodium hyaluronate preferably.
- Hyaluronic acid can be obtained by microbial culture or by extraction from hyaluronic acid-containing tissues.
- sodium biohyaluronate HA12 manufactured by Shiseido Co., Ltd.
- the content of hyaluronic acid is not particularly limited! /, But 0.00 to 5% by weight based on the total amount of the emulsified composition is preferable, and more preferably 0.005 to 2%. % By weight, particularly preferably 0.01 to ⁇ !% By weight.
- acetylated hyaluronic acid is a derivative obtained by acetylating at least a part of the hydroxyl group of hyaluronic acid and a salt thereof.
- the molecular weight of the acetylated hyaluronic acid used in the present invention is not particularly limited, but preferably 10,000 to 5,000,000, particularly preferably 100,000 to 2,000,000.
- the acetylation rate with respect to the hydroxyl group is not particularly limited, but it is preferable that the number of substitutions of the acetyl group in the repeating structural unit represented by the general formula (I) is 2 to 4 on average.
- the salts of acetylated hyaluronic acid include metal salts such as sodium salt, potassium salt, lithium salt, magnesium salt and calcium salt, basic amino acid salts such as lysine salt, arginine salt and histidine salt, ammonium salt and triethanolamine. And organic salts such as diisopropanolamine salts.
- Acetylated hyaluronic acid can be produced by methods well known to those skilled in the art, and the methods are disclosed in, for example, JP-A-6-6707 and JP-A-8-53501.
- a commercially available product may be used, for example, acetylated sodium hyaluronate (manufactured by Shiseido Co., Ltd.).
- the amount of Asechiru hyaluronic acid but are not particularly limited, 0.1 0001 ⁇ ;! weight 0/0 Ca preferably against emulsified total composition, more preferably (or 0. 0002-0 . 1 is a weight 0/0, in particular from 0.0005 to 0.01 weight 0/0 mosquitoes preferred Rere.
- the relative ratio of the blending amount of the alge colloid and the acetylated hyaluronic acid is not particularly limited. From the viewpoint of improving the feeling of use such as smoothness, when the amount of acetylated hyaluronic acid is set to 1, it is preferable that the alge colloid is 0.01 to 50 000 ⁇ , 0 ;; The power of is preferably ⁇ , 10 to; 1000 is particularly preferred. Further, the relative ratio of the blending amount of hyaluronic acid and acetylated hyaluronic acid is not particularly limited.
- the hyaluronic acid is preferably from 0.01 to 10,000; ⁇ , 0 ⁇ ! To 1000 It is better than some moss ⁇ ,; [0019]
- the emulsified form of the emulsified composition of the present invention is not limited to an oil-in-water emulsion composition and a water-in-oil emulsion composition, and an oil-in-water-in-water emulsion composition and an oil-in-water-in-oil emulsion composition.
- an oil-in-water emulsion composition is particularly preferred from the viewpoint of obtaining a favorable feeling of use such as a smooth feeling.
- Oils contained in the emulsified composition of the present invention include avocado oil, macadamia nut oil, corn oil, olive oil, rapeseed oil, evening primrose oil, castor oil, castor oil, tea seed oil, mountain tea flower oil, rice bran Power oil, jojoba oil, cacao butter, palm oil, stearic acid, cetanol, 1,3-butylene glycol, squalene, squalene, beef tallow, owl, beeswax, candelillaro, carnauba wax, whale wax, lanolin, liquid paraffin, polyoxyethylene (8 mol) oleyl alcohol ether, glyceryl monooleate, octyldodecyl myristate, cyclomethicone, dimethylpolysiloxane, diphenylpolysiloxane, etc., especially wildflower oil, jojoba oil, squalane, stearic acid, cetano
- the oil content is preferably 0.5 to 40% by weight, more preferably 2 to 30% by weight, and particularly preferably 3 to 20% by weight, based on the total amount of the emulsion composition.
- the emulsified composition of the present invention may further contain an emulsifier that enhances the emulsion stability.
- the emulsifier is not particularly limited as long as it is used for a skin external preparation, and examples thereof include anionic surfactants such as alkyl sulfates, acyl amino acid salts, fatty acid salts, polyoxyalkylene alkyl ethers, polyoxyalkylene fatty acids.
- Nonionic surfactants such as esters, polyoxyalkylene polyhydric alcohol fatty acid esters, polyhydric alcohol fatty acid esters, and sucrose fatty acid esters, cationic surfactants such as tetraalkyl ammonium salts, betaine types, sulfobetaine types, sulfoamino acids
- Amphoteric surfactants such as type, imidazolinium type, lecithin, lysolecithin and the like, and glycerin monostearate and hydrogenated soybean phospholipid are particularly preferred.
- the emulsified composition of the present invention may further contain a whitening component, an anti-inflammatory component, an antioxidant component, a thickener, a preservative, a stabilizer, a wetting agent, a pH adjuster, a fragrance, and the like. .
- Whitening ingredients include ascorbic acid and derivatives thereof and salts thereof, vitamin A or derivatives thereof, pantothenic acid or derivatives thereof, hydroquinone and derivatives thereof such as arbutin, resorcins such as ellagic acid, kojic acid, and lucinol. And derivatives thereof, chamomile ET, cystine and derivatives thereof, and salts thereof, grabrizine, glabrene, liquiritin, isoliquiritin, ferulic acid and derivatives thereof, and salts thereof, cuffic acid and derivatives thereof, and salts thereof.
- extracts deciduous extract, bracent extract, licorice extract, ripe mitsu extract, carotenoid-containing animal and plant extract, asparagus extract, endu bean extract, age extract, ogon extract, onionis Extract, seaweed extract, raspberry extract, cucumber extract, cuckoo extract, gokahi extract, coffee extract, rice bran extract, wheat germ extract, saicin extract, hawthorn extract, sun penz extract , Shirayuri extract, Peonies extract, Sempukuka extract, Soybean extract, Tea extract, Molasses extract, Tomato extract, Beechlen extract, Beech bud extract, Grape extract, Flow demanita extract, Hop extract, maikai extract, mokka extract, saxifrage extract, eucalyptus extract, okuinin extract, and rahan fruit extract, etc. It is below.
- Anti-inflammatory components include allantoin, calamine, glycyrrhizic acid or derivatives thereof, dallicylretinoic acid or derivatives thereof, zinc oxide, guaiazulene, tocopherol acetate, pyridoxine hydrochloride, menthol, camphor, turpentine oil, indomethacin, salicylic acid or derivatives thereof, etc. Is mentioned.
- Antioxidant components include tocopherol and derivatives thereof, butylhydroxyanisole, dibutylhydroxytoluene, sodium bisulfite, erythorbic acid and salts thereof, flavonoids, dartathione, dartathione peroxidase, dartathione-S-trans Examples include ferrase, catalase, superoxide dismutase, thioredoxin, taurine, thiotaurine, and hypotaurine.
- Examples of the thickener include sodium carboxymethyl cellulose, carboxybule polymer and / or salt thereof, hydroxyethyl cellulose, carrageenan, sodium alginate. And xanthan gum, sodium polyacrylate, polybulal alcohol, locust bean gum, guar gum, gelatin, and hydroxypropylmethylcellulose.
- a carboxybule polymer and / or a salt thereof can be preferably used.
- the carboxybule polymer is a water-soluble polymer having a carboxyl group, and is a polymer of acrylic acid.
- the carboxybule polymer and / or salt thereof is thickened by neutralizing the aqueous solution with alkali.
- the carboxybule polymer used in the present invention is not particularly limited, but those having a viscosity of 0.2% aqueous solution in the range of 1000 to 50000 mPa's are preferred, particularly those in the range of 5000 to 30000 mPa's. Force S is preferred.
- Carboxybule polymers can be produced by polymerizing acrylic acid in the usual way.
- commercially available products may be used.
- Examples of such commercially available products include Carbo Ponole 980, Carbo Ponole 981, Carbo Ponole 2984, Carbo Ponole 59 84, Carbo Pole ETD2050, Carbo Pole ultrezlO (manufactured by Noveon), Hibis® 103, Hibis® 104, Hibis® 105, Shintalen K, Shintalen L (manufactured by Wako Pure Chemical Industries, Ltd.), Junlon (manufactured by Nippon Pure Chemical Industries, Ltd.), and the like.
- the carboxybule polymer has an action of improving the emulsion stability and the viscosity stability against temperature change, and can be used suitably particularly when the emulsion composition is in the form of gel or cream. Furthermore, carboxybule polymers have advantages such as thixotropic properties, moisturizing action, resistance to microbial contamination, and superior quality uniformity compared to natural gums.
- the content of the carboxybule polymer is not particularly limited, but is preferably 0.0;! To 5% by weight, more preferably 0.02 to 2% by weight, based on the total amount of the emulsified composition. In particular, 0.05% to!% By weight is preferable.
- Examples of the preservative include paraoxybenzoates, benzalkonium chloride, and the like.
- the stabilizer examples include sodium sulfite, sodium hydrogen sulfite, dibutylhydroxytoluene, butylhydroxyanisole, edetic acid and salts thereof.
- wetting agent examples include polyvalent alcohols such as glycerin, ethylene glycol, propylene glycol, 1,3-butylene glycol, isopropylene glycol, and polyethylene glycol.
- polyvalent alcohols such as glycerin, ethylene glycol, propylene glycol, 1,3-butylene glycol, isopropylene glycol, and polyethylene glycol.
- pH regulators include inorganic acids such as hydrochloric acid, organic acids such as citrate, alkali hydroxides such as potassium hydroxide and sodium hydroxide, amines such as triethanolamine, diethanolamine, and diisoprono V-luamine. kind.
- Perfumes include spearmint oil, peppermint oil, linalool, winder green oil, sassafras oil, timber oil, bonito oil, thyme oil, sage oil, eucalyptus oil, lavender oil, canola oil, cinnamon oil, lime oil, lemon oil and Natural flavors such as orange oil, 1-menthol, e-camphor and the like can be mentioned.
- the dosage form of the emulsion composition of the present invention is not particularly limited, and examples thereof include creams, lotions, emulsions, and emulsion ointments. Creams, lotions and emulsions are particularly preferable. .
- the emulsified composition of the present invention is produced by mixing necessary components such as an emulsifier into an aqueous phase and an oil phase, respectively, and if necessary after heating and dissolving, mixing and emulsifying the aqueous phase and the oil phase.
- Power S can be.
- an emulsification method used in the present invention a general emulsification method can be used, and emulsification can be performed using a colloid mill, a homomixer, a high-pressure homogenizer, an ultrasonic emulsifier, or the like.
- the emulsified composition of the present invention can be suitably used as an external preparation for skin, such as a cosmetic preparation for external use for skin and a therapeutic agent for dry skin diseases, due to its smoothness and moisturizing effect during use.
- the invention is not limited to this.
- the usage amount and frequency of use of the emulsified composition of the present invention are not particularly limited, and can be appropriately selected depending on the purpose of use.
- Arge colloid (Arge colloid: manufactured by BOTTGER) 0 ⁇ lg, sodium hyaluronate (sodium biohyaluronate HA12: manufactured by Shiseido Co., Ltd., molecular weight 1.1 million to 1.6 million) 0.05 g, sodium acetylated hyaluronate (acetylated hyaluronic acid) Sodium acid: manufactured by Shiseido Co., Ltd., molecular weight: approx.
- 3 g of stearic acid, 4 g of wild tea flower oil, 0.4 g of jojoba oil, 0.2 g of cetanol, 3 g of squalane and glyceryl monostearate (Nikkor MGS-BMV: manufactured by Nikko Chemicanoles) Add lg and heat mix to 80 ° C This was used as the oil phase. Add the oil phase to the water phase, stir, mix and emulsify at 80 ° C, then cool to below 30 ° C to make a cream.
- Example 3 Comparison of Example 1 with water in place of acetylated sodium hyaluronate Comparative Example 1, Comparison with water in place of sodium hyaluronate Comparative Example 2, Comparison of water in place of algecoloid A cream was prepared as Example 3.
- Example 1 a mixture of water in place of the two components among the alge colloid, sodium hyaluronate, and sodium acetylated hyaluronate is referred to as Comparative Example 4, Comparative Example 5, and Comparative Example 6, and water is used instead of the above three components.
- a cream was prepared using as a control.
- the feeling of use was evaluated about the cream manufactured in Example 1 and Comparative Examples 1-6.
- the feeling of use was tested by 10 panelists, and the smoothness was evaluated according to the following criteria.
- smoothness is related to the feeling of friction felt by the finger or the skin of the application part during application, and therefore it is correlated with the viscosity after the emulsion composition of the present invention is thinly stretched and dried. Conceivable. Therefore, the smoothness at the time of use of the emulsified composition of the present invention was evaluated by measuring the viscosity at the time of drying.
- Example 1 For the creams prepared in Example 1 and Comparative Examples 1 to 6, using a rheometer (AR-1000N), the sample lg was evenly spread on a circular plate with a diameter of 4 cm and a sample table, and then with a dryer. After drying for 5 minutes, it was evaluated by measuring the viscosity at a measurement temperature of 25 ° C. and a shear stress of 500 Pa. A similar test was conducted for the control cream.
- AR-1000N rheometer
- Table 1 shows the test results.
- Comparative Example 1 containing an alge colloid and sodium hyaluronate Comparative Example 2 containing an alge colloid and sodium acetylated hyaluronate, Sodium hyaluronate and acetylated Comparative Example 3 containing sodium hyaluronate, acetylated
- Comparative Example 4 containing only sodium hyaluronate Comparative Example 5 containing only sodium hyaluronate
- Comparative Example 6 containing only alge colloid was ⁇ (normal) or X (poor)
- the smoothness when using the cream of Example 1 containing Alge colloid, sodium hyaluronate and acetylated sodium hyaluronate is
- Comparative Example 1 containing an alge colloid and sodium hyaluronate
- Comparative Example 2 containing an alge colloid and sodium acetylated hyaluronate
- Comparative Example 3 containing sodium hyaluronate and sodium acetylated hyaluronate
- Comparative Example 5 containing only sodium hyaluronate
- Comparative Example 6 containing only algecoloid was 3 ⁇ 08 5, 2 546, 0.985, 12. 910, 1. 115, 2.
- Example 2 which were high, but those of Example 1 containing anolegecolloid, sodium hyaluronate, and acetylated sodium hyaluronate It became clear that the viscosity after drying of the cream was as low as 0.510.
- Arge colloid (Arge colloid: manufactured by BOTTGER) 0 ⁇ lg, sodium hyaluronate (sodium biohyaluronate HA12: manufactured by Shiseido Co., Ltd.) 0.05g, sodium acetylated hyaluronate (acetylated sodium hyaluronate: manufactured by Shiseido Co., Ltd.) ) 0 ⁇ OOlg, concentrated glycerin lg, 1,3-butylene glycol 2g, carboxybule polymer (Carbopol ETD2050: Noveon, viscosity 4,000—7,500mPa-s (0.2%)) 0.15g and 0.27 g of potassium hydroxide was added to 87.4 g of purified water and heated to 80 ° C.
- stearic acid 2g wild tea flower oil 2g, jojoba oil 0.4g, cetanol 0.3g, myristic acid otatilde deci 2 g, squalene 2 g, and glyceryl monostearate (Nikkor MGS-BMV: manufactured by Nikko Chemicals Co., Ltd.) 0.3 g was added and heated and mixed at 80 ° C. to obtain an oil phase.
- the oil phase was added to the aqueous phase, stirred and mixed at 80 ° C to emulsify, and then cooled to 30 ° C or lower to produce an emulsion. Evaluation of the feeling of use of the obtained emulsion was carried out in the same manner as in the above test example by a use test by 10 panelists. The results are shown in Table 2.
- Example 2 Contains colloids, sodium hyaluronate, and acetylated sodium hyaluronate The emulsion of Example 2 which had it became clear that it had a smooth use feeling.
- Hydrogenated soybean phospholipid (PHOSPHOLIPON90H: manufactured by Hitch Holstein & Power Company) 0.5g was added to 5g of 1,3-butylene glycol, dissolved at 65 ° C, cooled to 30 ° C, and the oil phase did.
- Arge colloid (Arge colloid: manufactured by BOTTGER) 0 ⁇ lg, Sodium hyaluronate (Bio-hyaluronate sodium HA12: manufactured by Shiseido) 0 ⁇ 05 g, Acetylated sodium hyaluronate (acetylated sodium hyaluronate: manufactured by Shiseido) ) 0.001 g, Carboxybule polymer (Syntalen L: Wako Pure Chemical Industries, viscosity 7,000-14,000 mPa-s (0.2%))) 0.1 g, concentrated glycerin 3 g and potassium hydroxide 0.044 g Purified Water was added to 91.2 g and stirred at room temperature to obtain an aqueous phase.
- the aqueous phase was added to the oil phase, and the mixture was stirred and mixed at 30 ° C to produce a lotion. Evaluation of the feeling of use of the obtained lotion was carried out in the same manner as in the above test example by a use test with 10 panelists. The results are shown in Table 3.
- the present invention provides an emulsified composition containing an alge colloid and hyaluronic acid and having a smooth feeling of use.
- the emulsified composition of the present invention can be used in the cosmetics industry as, for example, a cosmetic for external use on the skin, and can be used in the pharmaceutical industry as a therapeutic agent for dry skin diseases, and has industrial applicability.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Cosmetics (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006-228760 | 2006-08-25 | ||
JP2006228760A JP2008050311A (ja) | 2006-08-25 | 2006-08-25 | 使用感の良い乳化組成物 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008023574A1 true WO2008023574A1 (fr) | 2008-02-28 |
Family
ID=39106661
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2007/065598 WO2008023574A1 (fr) | 2006-08-25 | 2007-08-09 | Formule en émulsion de sensation d'utilisation agréable |
Country Status (5)
Country | Link |
---|---|
JP (1) | JP2008050311A (ja) |
KR (1) | KR20090057044A (ja) |
CN (1) | CN101505719A (ja) |
TW (1) | TW200817040A (ja) |
WO (1) | WO2008023574A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102872482A (zh) * | 2012-10-22 | 2013-01-16 | 温志仁 | 一种人体润滑液 |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6092582B2 (ja) * | 2012-11-08 | 2017-03-08 | 株式会社ミルボン | 頭皮頭髪用化粧料 |
CN104224853A (zh) * | 2013-06-24 | 2014-12-24 | 李明贞 | 具强化葡萄糖胺吸收效果的乳霜组合物 |
CN104288090A (zh) * | 2013-07-17 | 2015-01-21 | 李明贞 | 具强化药物吸收效果载体 |
EP2835130A1 (en) * | 2013-08-05 | 2015-02-11 | Polichem SA | Composition for skin anti-ageing treatment |
CN106913495A (zh) * | 2015-12-24 | 2017-07-04 | 上海珍萃生物科技有限公司 | 润养护肤精露及其制备方法 |
CN106176286B (zh) * | 2016-08-30 | 2019-05-28 | 华熙生物科技股份有限公司 | 透明质酸皮肤护理膜及制备方法和应用 |
CN114939191B (zh) * | 2022-04-20 | 2023-09-08 | 华熙生物科技股份有限公司 | 一种水溶性润滑液及其制备方法和应用 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61204109A (ja) * | 1985-03-07 | 1986-09-10 | Eisai Co Ltd | 乳化型の外用組成物 |
JPH0290936A (ja) * | 1988-09-26 | 1990-03-30 | Kobayashi Kose Co Ltd | 水中油型乳化組成物 |
JPH0971602A (ja) * | 1995-06-29 | 1997-03-18 | Shiseido Co Ltd | 低分子量アセチル化ヒアルロン酸及び皮膚柔軟化剤 |
JPH09255562A (ja) * | 1996-03-28 | 1997-09-30 | Shiseido Co Ltd | 複合エマルジョンおよびその製造方法 |
JPH10265332A (ja) * | 1997-03-26 | 1998-10-06 | Shiseido Co Ltd | 水中油型乳化組成物 |
JPH10279425A (ja) * | 1997-03-31 | 1998-10-20 | Shiseido Co Ltd | 皮膚外用剤 |
JP2001048769A (ja) * | 1999-08-05 | 2001-02-20 | Shiseido Co Ltd | 皮膚外用剤 |
JP2001233755A (ja) * | 2000-02-25 | 2001-08-28 | Yakult Honsha Co Ltd | 皮膚外用剤組成物 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005139070A (ja) * | 2003-11-04 | 2005-06-02 | Kanebo Cosmetics Inc | 皮膚化粧料 |
-
2006
- 2006-08-25 JP JP2006228760A patent/JP2008050311A/ja active Pending
-
2007
- 2007-08-09 WO PCT/JP2007/065598 patent/WO2008023574A1/ja active Application Filing
- 2007-08-09 CN CNA2007800316905A patent/CN101505719A/zh active Pending
- 2007-08-09 KR KR1020097006071A patent/KR20090057044A/ko not_active Application Discontinuation
- 2007-08-15 TW TW96130182A patent/TW200817040A/zh unknown
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61204109A (ja) * | 1985-03-07 | 1986-09-10 | Eisai Co Ltd | 乳化型の外用組成物 |
JPH0290936A (ja) * | 1988-09-26 | 1990-03-30 | Kobayashi Kose Co Ltd | 水中油型乳化組成物 |
JPH0971602A (ja) * | 1995-06-29 | 1997-03-18 | Shiseido Co Ltd | 低分子量アセチル化ヒアルロン酸及び皮膚柔軟化剤 |
JPH09255562A (ja) * | 1996-03-28 | 1997-09-30 | Shiseido Co Ltd | 複合エマルジョンおよびその製造方法 |
JPH10265332A (ja) * | 1997-03-26 | 1998-10-06 | Shiseido Co Ltd | 水中油型乳化組成物 |
JPH10279425A (ja) * | 1997-03-31 | 1998-10-20 | Shiseido Co Ltd | 皮膚外用剤 |
JP2001048769A (ja) * | 1999-08-05 | 2001-02-20 | Shiseido Co Ltd | 皮膚外用剤 |
JP2001233755A (ja) * | 2000-02-25 | 2001-08-28 | Yakult Honsha Co Ltd | 皮膚外用剤組成物 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102872482A (zh) * | 2012-10-22 | 2013-01-16 | 温志仁 | 一种人体润滑液 |
Also Published As
Publication number | Publication date |
---|---|
CN101505719A (zh) | 2009-08-12 |
JP2008050311A (ja) | 2008-03-06 |
TW200817040A (en) | 2008-04-16 |
KR20090057044A (ko) | 2009-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008023574A1 (fr) | Formule en émulsion de sensation d'utilisation agréable | |
JP5433128B2 (ja) | 皮膚外用剤 | |
JP5421554B2 (ja) | αゲルを含む組成物 | |
JP2013107862A (ja) | ジェル状皮膚化粧料 | |
JP2008074725A (ja) | 保湿剤、アルギナーゼ活性促進剤、細胞賦活剤、コラーゲン産生促進剤、ヒアルロン酸産生促進剤、抗酸化剤、及び中性脂肪蓄積抑制剤 | |
RU2755617C2 (ru) | Композиции для местного нанесения, содержащие ретиноиды, и полимерные очищающие агенты с низким раздражающим действием | |
JP5393998B2 (ja) | 乳液状化粧料 | |
JP5125122B2 (ja) | アダパレン含有外用剤組成物 | |
JP2023076747A (ja) | レチノイドの活性を高める方法 | |
JP4201091B1 (ja) | 保湿剤、抗老化剤、抗酸化剤及び皮膚外用剤 | |
JP4799335B2 (ja) | 保湿剤、細胞賦活剤、コラーゲン産生促進剤、ヒアルロン酸産生促進剤、抗酸化剤及び中性脂肪蓄積抑制剤 | |
JP2005120108A (ja) | コラーゲン合成促進剤及びコラーゲン代謝賦活剤 | |
WO2007099757A1 (ja) | 乳化組成物 | |
JP2004107242A (ja) | 乾燥肌改善用キット | |
JP2021526127A (ja) | ナノエマルジョン及びその製造方法 | |
JP7349047B1 (ja) | 水膨潤性の皮膜形成型外用剤基剤 | |
JP4365281B2 (ja) | Dfa含有皮膚外用剤、化粧料、眼科用液剤 | |
JP4515423B2 (ja) | 保湿剤、細胞賦活剤、及び抗酸化剤 | |
JP2009057309A (ja) | 皮膚外用剤及び保湿剤 | |
JP2006347934A (ja) | グルタチオン産生促進剤 | |
WO2023188109A1 (ja) | 水膨潤性の皮膜形成型外用剤基剤 | |
JP5013726B2 (ja) | 保湿剤、細胞賦活剤、抗酸化剤、及びコラゲナーゼ阻害剤 | |
JP2009046425A (ja) | 皮膚外用剤及び保湿剤 | |
WO2016084709A1 (ja) | 外用組成物 | |
JP2001270824A (ja) | 経皮吸収促進性皮膚外用剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200780031690.5 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07792250 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020097006071 Country of ref document: KR |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07792250 Country of ref document: EP Kind code of ref document: A1 |